These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17259865)

  • 1. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons.
    Knudsen S; Mikkelsen JD; Jennum P
    Neuroreport; 2007 Jan; 18(1):77-9. PubMed ID: 17259865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.
    Overeem S; Verschuuren JJ; Fronczek R; Schreurs L; den Hertog H; Hegeman-Kleinn IM; van Duinen SG; Unmehopa UA; Swaab DF; Lammers GJ
    J Neuroimmunol; 2006 May; 174(1-2):187-91. PubMed ID: 16563524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?
    Fontana A; Gast H; Reith W; Recher M; Birchler T; Bassetti CL
    Brain; 2010 May; 133(Pt 5):1300-11. PubMed ID: 20403960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voxel-based morphometry in hypocretin-deficient narcolepsy.
    Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ
    Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and hypocretin studies in Korean patients with narcolepsy.
    Hong SC; Leen-Kim ; Park SA; Han JH; Lee SP; Lin L; Okun M; Nishino S; Mignot E
    Sleep; 2002 Jun; 25(4):440-4. PubMed ID: 12071546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy.
    Knudsen S; Mikkelsen JD; Bang B; Gammeltoft S; Jennum PJ
    Neuropediatrics; 2010 Oct; 41(5):217-22. PubMed ID: 21210337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
    Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
    Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy.
    Dauvilliers Y; Bauer J; Rigau V; Lalloyer N; Labauge P; Carlander B; Liblau R; Peyron C; Lassmann H
    JAMA Neurol; 2013 Oct; 70(10):1305-10. PubMed ID: 23939463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
    Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K
    Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice.
    Katzav A; Arango MT; Kivity S; Tanaka S; Givaty G; Agmon-Levin N; Honda M; Anaya JM; Chapman J; Shoenfeld Y
    J Autoimmun; 2013 Sep; 45():24-30. PubMed ID: 23834844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.
    Fronczek R; Lammers GJ; Balesar R; Unmehopa UA; Swaab DF
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5466-70. PubMed ID: 15985489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
    Cvetkovic-Lopes V; Bayer L; Dorsaz S; Maret S; Pradervand S; Dauvilliers Y; Lecendreux M; Lammers GJ; Donjacour CE; Du Pasquier RA; Pfister C; Petit B; Hor H; Mühlethaler M; Tafti M
    J Clin Invest; 2010 Mar; 120(3):713-9. PubMed ID: 20160349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination.
    van der Heide A; Hegeman-Kleinn IM; Peeters E; Lammers GJ; Fronczek R
    J Neuroimmunol; 2015 Jun; 283():58-62. PubMed ID: 26004157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
    Thannickal TC; Nienhuis R; Siegel JM
    Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased immune complexes of hypocretin autoantibodies in narcolepsy.
    Deloumeau A; Bayard S; Coquerel Q; Déchelotte P; Bole-Feysot C; Carlander B; Cochen De Cock V; Fetissov SO; Dauvilliers Y
    PLoS One; 2010 Oct; 5(10):e13320. PubMed ID: 20967199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.